These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21360707)

  • 1. Particle aerosolisation and break-up in dry powder inhalers: evaluation and modelling of impaction effects for agglomerated systems.
    Wong W; Fletcher DF; Traini D; Chan HK; Crapper J; Young PM
    J Pharm Sci; 2011 Jul; 100(7):2744-54. PubMed ID: 21360707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particle aerosolisation and break-up in dry powder inhalers: evaluation and modelling of the influence of grid structures for agglomerated systems.
    Wong W; Fletcher DF; Traini D; Chan HK; Crapper J; Young PM
    J Pharm Sci; 2011 Nov; 100(11):4710-21. PubMed ID: 21695695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Particle aerosolisation and break-up in dry powder inhalers 1: evaluation and modelling of venturi effects for agglomerated systems.
    Wong W; Fletcher DF; Traini D; Chan HK; Crapper J; Young PM
    Pharm Res; 2010 Jul; 27(7):1367-76. PubMed ID: 20372989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coupled in silico platform: Computational fluid dynamics (CFD) and physiologically-based pharmacokinetic (PBPK) modelling.
    Vulović A; Šušteršič T; Cvijić S; Ibrić S; Filipović N
    Eur J Pharm Sci; 2018 Feb; 113():171-184. PubMed ID: 29054499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential and constraints for the application of CFD combined with Lagrangian particle tracking to dry powder inhalers.
    Sommerfeld M; Cui Y; Schmalfuß S
    Eur J Pharm Sci; 2019 Feb; 128():299-324. PubMed ID: 30553814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of loaded carrier mass and formulation mass on aerosolization efficiency in dry powder inhaler devices.
    Ooi J; Gill C; Young PM; Traini D
    Curr Drug Deliv; 2015; 12(1):40-6. PubMed ID: 25146438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-scale modelling of powder dispersion in a carrier-based inhalation system.
    Tong Z; Kamiya H; Yu A; Chan HK; Yang R
    Pharm Res; 2015 Jun; 32(6):2086-96. PubMed ID: 25511919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuning aerosol performance using the multibreath Orbital® dry powder inhaler device: controlling delivery parameters and aerosol performance via modification of puck orifice geometry.
    Zhu B; Young PM; Ong HX; Crapper J; Flodin C; Qiao EL; Phillips G; Traini D
    J Pharm Sci; 2015 Jul; 104(7):2169-76. PubMed ID: 25931324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring Bipolar Charge and Mass Distributions of Powder Aerosols by a Novel Tool (BOLAR).
    Wong J; Lin YW; Kwok PC; Niemelä V; Crapper J; Chan HK
    Mol Pharm; 2015 Sep; 12(9):3433-40. PubMed ID: 26222019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-breath dry powder inhaler for delivery of cohesive powders in the treatment of bronchiectasis.
    Young PM; Salama RO; Zhu B; Phillips G; Crapper J; Chan HK; Traini D
    Drug Dev Ind Pharm; 2015 May; 41(5):859-65. PubMed ID: 24811055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational fluid dynamics (CFD) assisted performance evaluation of the Twincer™ disposable high-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Woolhouse R; Wynn E
    J Pharm Pharmacol; 2012 Sep; 64(9):1316-25. PubMed ID: 22881443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deposition and fine particle production during dynamic flow in a dry powder inhaler: a CFD approach.
    Milenkovic J; Alexopoulos AH; Kiparissides C
    Int J Pharm; 2014 Jan; 461(1-2):129-36. PubMed ID: 24296048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W; Ticehurst M; Nokhodchi A
    Int J Pharm; 2012 Feb; 423(2):184-94. PubMed ID: 22197772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the cellular uptake of respiratory aerosols delivered from different devices equivalent?
    Ong HX; Traini D; Loo CY; Sarkissian L; Lauretani G; Scalia S; Young PM
    Eur J Pharm Biopharm; 2015 Jun; 93():320-7. PubMed ID: 25930239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact angles as an alternative way to improve aerosolisation of powders for inhalation?
    Adi S; Tong Z; Chan HK; Yang R; Yu A
    Eur J Pharm Sci; 2010 Oct; 41(2):320-7. PubMed ID: 20615465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacopeial methodologies for determining aerodynamic mass distributions of ultra-high dose inhaler medicines.
    Wong W; Crapper J; Chan HK; Traini D; Young PM
    J Pharm Biomed Anal; 2010 Mar; 51(4):853-7. PubMed ID: 19932579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the Use of Computational Fluid Dynamics (CFD) Modelling to Design Improved Dry Powder Inhalers.
    Fletcher DF; Chaugule V; Gomes Dos Reis L; Young PM; Traini D; Soria J
    Pharm Res; 2021 Feb; 38(2):277-288. PubMed ID: 33575958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of high dose aerosols from dry powder inhalers.
    Grasmeijer F; Hagedoorn P; Frijlink HW; de Boer AH
    Int J Pharm; 2012 Nov; 437(1-2):242-9. PubMed ID: 22939966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.